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FIG. 3.-Comfort has been achieved, and operator and patient both relax.
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POLIOVIRUS-INDUCED RNA POLYMERASE AND THE EFFECTS
OF VIRUS-SPECIFIC INHIBITORS ON ITS PRODUCTION*
By DAVIDBALTIMORE, HANS J. EGGERS, RICHARD M. FRANILIN,t AND IGOR TAMM
THE ROCKEFELLER INSTITUTE
Communicated by Frank L. Horsfall, Jr., April 19, 1963
In the last few years new experimental approaches have been found to the study
of virus-specific biosynthesis in animal -virus reproduction. This report describes
recent results obtained in the study of the mechanism of action of two virus-specific
inhibitors 1ii6 and provides evidence which bears on the virus-specific nature of the
virus-induced RNA polymerase.i17-20
2-(a-Hydroxybenzyl)-benzimnidazole (HB'-, and guanidine4' 10-16 inhibit
completely and specifically the multiplication of many small, RNA-containing,
lipid-free animal viruses (picornaviniseS21) . These compounds have no effect or
only minor effects on the multiplication of viruses which belong to other major
groups.1' 2, 10 Similarly, the metabolic activities and growth rate of host cells are
unaffected or oniy minimally affected by HBB, I o guanidine.12, 13, 16 Mutants of
844 BIOCHEMISTRY: BALTIMORE ET AL. PROC. N. A. S.
HBB- or guanidine-sensitive viruses have been obtained which are either drug-
resistant14' , 11,14 or drug-dependent.6 7 14,22 It is known that HBB prevents the
synthesis of the viral RNA of drug-sensitive viruses,3 8 but is required for replica-
tion of the RNA of drug-dependent mnutants.9 There is some evidence that guanidine
has similar effects.15' 16
Recently, a virus-induced polymerase which is thought to be responsible for viral
RNA synthesis has been found in Mengovirus-infected cells.17-20 The enzyme has
the properties of an RNA-dependent RNA polymerase, although dependence has
yet to be directly demonstrated. The finding of a new RNA polymerase in cells in-
fected with a picornavirus suggested a study of the effects of HBB and guanidine on
such a virus-induced RNA-synthesizing system. Since HBB and guanidine have
no effect on Mengovirus multiplication, it was necessary first to demonstrate
virus RNA polymerase in cells infected with a drug-sensitive virus. We have found
such an enzyme system in the cytoplasm of HeLa cells infected with poliovirus
types 1 or 2, and have carried out a study of the effects of the virus-specific inhibitors
on the appearance and activity of this enzyme system. The appearance of polio-
virus RNA polymerase was also investigated in cells infected with drug-resistant
or drug-dependent mutants.
Materials and Methods.-Viruses: Poliovirus type 2 (strain P 712-Ch-2ab),
adapted to HeLa cells, was used in most experiments; in some, poliovirus type 1
(strain Brunhilde) and two of its variants were used; one was resistant to 100 pig
guanidine per ml, and the other was dependent on guanidine. The dependent vari-
ant was grown and titrated in the presence of 100 ,ug/ml of guanidine. Poliovirus
type 1 strains were kindly made available by Dr. Nada Ledinko, The Public Health
Research Laboratories of the City of New York.
Virus RNA polymerase: HeLa cells were grown in suspension in 150 ml volumes
of Eagle's spinner medium23 with 4 mM glutamine and 10% calf serum. When the
number reached 5 to 6 X 105 cells/ml, the cells were harvested by centrifugation and
redispersed in 2 ml of undiluted poliovirus stock at a multiplicity of 5 to 10. After
a 0.25-hr adsorption period at room temperature, 150 ml of warm medium without
serum was added and incubation at 37°C begun (zero time). After the appropriate
length of time, cells were harvested by centrifugation, dispersed in 0.25 M sucrose
containing 0.001 M MgCl2 (sucrose-Mg), recentrifuged, and either used directly,
or frozen as a pellet. In most experiments (exceptions are noted) cells were homog-
enized in an all glass homogenizer after addition of 20-40 volumes of ice-cold
water. All further operations were carried out at 0-4"C. The cell homogenate
was adjusted to a final concentration of 0.1 II Tris-HCl buffer (pH 7.6), 0.005 211
MgCl2, and 0.5 M NaCl, and after 5-10 min, the viscous suspension was diluted
2-fold with water to reduce viscosity, and the nuclei, whole cells, and released nu-
cleoprotein removed by centrifugation at 600 X g for 10 min. The suspension was
then centrifuged at 78,000 X g for 1.5-2.0 hr, and the resulting pellet dispersed in
sucrose-Mg at 2.5-10 mg of protein/ml. Details of this method will be published.19
Such a preparation, which could be stored at - 20'C for at least one week with re-
tention of 75% or more of the initial activity, will be referred to as an enzyme
preparation. Assay conditions were identical to those used for the Mengovirus poly-
merase.17'-9 The C14-nucleoside triphosphates used were purchased from Schwarz
BioResearch, Inc.
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TABLE 1
VIRUS RNA POLYMERASE ACTIVITY IN HELA CELLS INFECTED WITH POLIOVIRus 2
cpm/nig protein
Infected Uninfected
Complete (GTP-C14) 155 4
-ATP, -UTP, -CTP 5
+ 5 mM Mn++ 32
Complete (ATP-C'4) 123 36
-UTP, -GTP, -CTP 47 34
Complete (UTP-C14) 322 85
Infected cells were harvested 5 hr after infection with poliovirus type 2, suspended in sucrose-Mg
and homogenized in a VirTis homogenizer.24 The nuclei (600 X g, 8 min) and mitochondria(10,000 X g, 10 min) were discarded and the microsomal fraction (105,000 X g, 1 hr) was resus-
pended in sucrose-Mg at about 5 mg/ml. The assay mixture (0.5 ml) contained 1 pug actinomycin,
20 pg phosphoenolpyruvate kinase, 5 pmoles phosphoenolpyruvate, 5 pmoles magnesium acetate,
30 jumoles Tris-HCl buffet (pH 8.1) and 0.2 ml of the microsomal suspension. Either 73 mpmoles
of GTP-C14 (2,100 cpm/mpmole), 96 mpmoles of ATP-C14 (690 cpm/mpmole), or 25 m;smoles of
UTP-C14 (7,250 cpm/mp&mole) was added to each tube along with approximately equal amounts of
the other nucleoside triphosphates which were unlabeled. After 15 min incubation at 370 C, the
reaction mixture was chilled in ice and 0.5 ml of cold 0.1 M sodium pyrophosphate added,25 followed
by 5 ml of cold 0.5 M perchloric acid (PCA). After 10 min in ice, the tubes were centrifuged in the
cold and the resulting precipitate washed 3 times with PCA. After one wash in ethanol-ether (1: 1)
the precipitate was dissolved in 2 ml of concentrated formic acid, dried onto aluminum planchets,
and counted in a windowless gas-flow counter. Protein was determined by the method ef Lowry
et al.' All results were corrected by subtraction of the counting rate of an unincubated sample.
Results.-Virus RNA polymerase in cells infected with poliovirus 2: As is shown
in Table 1, microsomal preparations from poliovirus-infected HeLa cells incor-
porated forty times more GTP-C14 than did similar preparations from uninfected
cells. Omission of unlabeled triphosphates markedly depressed incorporation, and
the enzymatic activity was inhibited by manganese ions, as has been demonstrated
for the Mengovirus RNA polymerase.17-20 With C14-labeled ATP and UTP, the
microsomal preparations from infected cells showed 3-4 times greater incorporating
activity than those from control cells.
The kinetics of virus RNA polymerase appearance in poliovirus-infected HeLa
cells are shown in Figure 1. The polymerase activity did not appear until after 2 hr
of infection, rose to a maximum at 4 hr, and then declined. The decrease was
variable from experiment to experiment, and the apparent rise between 5 and 6 hr
shown in Figure 1 is due to variation. The appearance of virus polymerase corre-
lates well with the increase in virus (Fig. 1) and infectious viral RNA.28 However,
the results suggest that maximal amounts of virus RNA polymerase are made before
the full yields of virus RNA and virus particles are produced.
Inhibition by guanidine and HBB of virus RNA polymerase appearance in infected
cells: Guanidine had no effect on the activity of virus RNA polymerase prepara-
tions in vitro (Table 2). The lack of effect was evident at pH 8.1, the usual pH for
assay, as well as at pH 7.5 or 7.2. HBB also had no effect on incorporation of
GTP-C14 into an acid insoluble product in the cell-free system.
In contrast to the lack of direct effect on the polymerase, both compounds pre-
vented the appearance of the virus RNA polymerase activity in HeLa cells infected
with poliovirus. As is shown in Table 3, the microsome fraction from cells infected
in the presence of HBB or guanidine incorporated no more GTP-C14 than did the
microsome fraction from uninfected control cells.
It was next of interest to determine the effect of guanidine and HBB when added
during the exponential increase phase in virus multiplication. Guanidine or HBB
was added at 3 hr postinfection when 50 per cent of the enzyme activity had al-
ready appeared in the infected cells. After addition of either compound, there was
not only no further increase in enzyme, but in fact a marked decrease occurred by
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FIG. l.-Specific activity of virus RNA polymerase after infection of
HeLa cells with poliovirus type 2; growth curve of virus. Enzyme
preparations were made from infected cells which had been incubated
for various periods. Activity was assayed as described in Table 1, with
32 mpmoles of GTP-C14 (2,100 cpm/mIumole) as precursor. Results
are expressed as cpm/mg/protein.
Plaque assays of virus were carried out in primary monkey kidney
cell cultures.27
TABLE 2
EFFECT OF GTJANIDINE AND HBB ON THE ACTIVITY OF THE VnRus RNA POLYMERASE
cpm
Complete 155
-ATP, -CTP, -UTP 5
+ 0.1 M guanidine 171
Complete (pH 7.5) 112
+ 0. 1 M guanidine 101
Complete 568
+0.15mMHBB 585
The conditions of experiments with guanidine were identical to those described in Table 1. GTP-
C14was used as the labeled nucleotide. The experiment with HBB shows higher incorporation values
since the samples were collected at 4.25 rather than 5 hr, the enzyme preparation employed was made
by water homogenization (cf. Materials and Methods) and 32 mpmoles of GTP-C'4 (5,080 cpm/
mpmole) was added to each reaction mixture.
4.25 hr (Table 4). Thus, the enzyme already formed appeared to have a short
life. That the inactivation was not due to a direct effect of HBB or guanidine on
the enzyme system is suggested by the fact that addition of the compounds to the
cell-free GTP-C'4-incorporating system had no effect on its activity (Table 2).
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TABLE 3
INHIBITION BY GUANIDINE AND HBB OF VIRUS RNA POLYMERASE APPEARANCE IN HELA
CELLS INFECTED WITH POLIOVIRIUS 2
Compound present epm/mg protein
None 209
Guanidine, 1 mM 12
None 582
HBB, 0.2mM 12
After infection, cells were resuspended in medium containing guanidine or HBB. Enzyme was prepared at 5 hr
postinfection for the guanidine experiment and 4.25 hr for the HBB experiment, and assayed by the procedure
described in Table 1. 73 mpmoles of GTP-C14 (2,100 cpm/mgmole) was used for the guanidine experiment and
32 mpmoles of GTP-C14 (5,080 cpm/mpmole) for the HBB experiment.
TABLE 4
INHIBITION BY GUANIDINE AND HBB OF VIRUS RNA POLYMERASE APPEARANCE IN HELA
CELLS INFECTED WITH POLIOVIRUJS 2
Compound added Time of harvest, hr cpm/mg protein
None 3 252
None 4.25 582
Guanidine at 3 hr 4.25 7
HBB at 3 hr 4.25 64
1 mM guanidine or 0.2 mM HBB was added to infected cells 3 hr after the virus adsorption period. Enzyme
preparations were assayed as described in Table 1, with 32 mjmoles of GTP-C14 (5,080 cpm/mpmoles) as precursor.
Virus RNA polymerase in cells infected with drug-resistant or drug-dependent mutants
of poliovirus 1; effects of guanidine: To obtain additional evidence as to the virus-
specific nature of the RNA polymerase which appears in the cytoplasm of polio-
virus-infected cells, experiments were undertaken with drug-resistant and drug-
dependent mutants. The drug-resistant mutant of poliovirus I multiplied to high
yields in the presence of 1 mM guanidine; the dependent mutant required guanidine
for replication. Experiments were carried out to determine whether the resistant
mutant could initiate enzyme production in spite of the presence of guanidine, and
whether guanidine was required for enzyme production by the dependent mutant.
The results of these experiments are summarized in Table 5. As can be seen, virus
RNA polymerase was not demonstrable in cells which had been infected with the
drug-sensitive wild type of poliovirus 1 and treated with guanidine. Enzyme ac-
tivity was demonstrable in cells infected with drug-resistant virus regardless of
whether guanidine was present in the growth medium. While the activity in
untreated cells infected with the resistant mutant was significantly lower than that
in such cells infected with the sensitive wild type, the yields of infectious particles
were also lower. Finally, enzyme activity developed in cells infected with the drug-
TABLE 5
EFFECT OF GUANIDINE ON THE APPEARANCE OF THE VIRUS RNA POLYMERASE IN HELA CELLS
INFECTED WITH DRUG-RESISTANT OR DRUG-DEPENDENT POLIOVIRUJS MUTANTS
Guanidine, 1 mM,
present during cpm/mg
Poliovirus 1 infection protein
Sensitive (wild type) 480
it + 3
Resistant mutant 206
+ 362
Dependent mutant 3
+ 472
Cells were infected with various cloned mutant strains of poliovirus type 1 and infection allowed to proceed for
4 hr in the presence or absence of 1.0 mM guanidine. Enzyme preparations were assayed as described in Table 1,
with 32 mpmoles of GTP-C'4 (5,080 cpm/mjsmole) as precursor.
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dependent virus only when the cells were incubated in the presence of guanidine.
It should be emphasized that virus RNA polymerase, produced in cells infected
with drug-dependent virus in the presence of guanidine, did not require the com-
pound for activity in the cell-free system. The virus RNA polymerase from such
cells was sensitive to manganese, as was the enzyme produced in guanidine-treated
cells infected with resistant virus.
Discussion.-From the foregoing results, it appears that poliovirus, like Mengo-
virus, causes the appearance in infected cell cultures of an RNA polymerase activity
which is either not present in the uninfected cells, or is present at less than 2 per
cent of the maximal level in the infected culture. The time course of enzyme ap-
pearance, and the correlation of activity with the growth of guanidine-sensitive,
-resistant, or -dependent virus strains implicates the enzyme in the process of viral
RNA synthesis.
As to the mechanism of action of guanidine and HBB, there is reason to believe
that they specifically prevent virus-induced protein synthesis. Biochemical stud-
ies on cells infected with bacteriophage or DNA animal viruses have provided
evidence that new enzyme activities and new protein antigens appear in cells after
infection.29 3 In the case of bacteriophage infection a new class of messenger
RNA's made soon after infection appear to determine the specificities of the new
proteins.3' As for the reproduction of DNA animal viruses, it is known that syn-
thesis of RNA is a necessary prerequisite.32'. 3
Mengovirus, a small lipid-free animal virus (picornavirus), causes, within an
hour after infection, inhibition of cellular RNA and protein synthesis by separate
processes which are inhibitable by puromycin and fluorophenylalanine and which
therefore involve protein synthesis.34 Poliovirus has similar effects.35 iMlengo-
virus and poliovirus also cause the synthesis of a new RNA polymerase and of coat
protein. There is reason to believe that viral RNA or a copy of viral RNA supplies
the information for the synthesis of these new proteins, i.e., two presumed inhibitors
of cellular macromolecular synthesis, the polymerase, and the coat protein.20 34, 36
The observations that the RNA's of f2 bacteriophage37 and of poliovirus38 can
in vitro determine the specificity of their respective coat proteins further strengthens
the concept of viral RNA acting as a messenger RNA.
Both HBB and guanidine suppress the production of virus RNA polymerase in
cells infected with drug-sensitive virus and also prevent the synthesis of virus
RNA and coat protein. Furthermore, it has been found that guanidine can at
least partially prevent the virus-induced depression of cellular RNA synthesis16' 39
and that both guanidine'0 and HBB' markedly palliate viral cytopathic effects.
These facts, taken in conjunction with the concept that the viral RNA acts as a
messenger RNA to provide the information for the synthesis of the new proteins,
suggest that HBB and guanidine can interfere with the messenger function of viral
RNA. In the case of the drug-dependent mutants, it would appear that the com-
pound is required for the messenger function of viral RNA to be manifest. Since
many of the details of the infective process are yet to be worked out, a more general
form of this hypothesis may be useful, namely, that these compounds inhibit most
if not all virus-induced protein synthesis. In any event, the effects of HBB and
guanidine are reversible: no permanent damage to the viral RNA results from treat-
ment of infected cells with these compounds.3 12
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